Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

Autor:	Blauvelt, Andrew, de Bruin-Weller, Marjolein, Gooderham, Melinda, Cather, Jennifer C, Weisman, Jamie, Pariser, David, Simpson, Eric L, Papp, Kim A, Hong, H Chih-Ho, Rubel, Diana, Foley, Peter, Prens, Errol, Griffiths, Christopher E M, Etoh, Takafumi, Pinto, Pedro Herranz, Pujol, Ramon M, Szepietowski, Jacek C, Ettler, Karel, Kemény, Lajos, Zhu, Xiaoping, Akinlade, Bolanle, Hultsch, Thomas, Mastey, Vera, Gadkari, Abhijit, Eckert, Laurent, Amin, Nikhil, Graham, Neil M H, Pirozzi, Gianluca, Stahl, Neil, Yancopoulos, George D, Shumel, Brad
Zdroj:	In The Lancet 10-16 June 2017 389(10086):2287-2303
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu